drugset / Trial / NCT01914627
Parallel Group Trial to Evaluate the Efficacy and Safety of Loion® Compared to 10% Salicylic Acid in Patients With Chronic Psoriasis Capitis
Phase 2
Completed
90 enrolled
G. Pohl-Boskamp GmbH & Co. KG
Universitätsklinikum Hamburg-Eppendorf · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The study will be conducted to evaluate the efficacy and safety of a topical dimeticone formulation (Loion®) compared to 10% salicylic acid in octyl-dodecanol with 15% Macrogol-4-laurylether for the removal of scaling in patients with chronic psoriasis capitis (scalp psoriasis).
Timeline
- Start
- 2013-08
- Primary completion
- 2014-01
- Completion
- 2014-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dimethicone | Unknown | — | Topical |
| Comparator | salicylic acid | Small molecule | 10 % | Topical |